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ABSTRACT  We  investigated  the  interaction  and  transport  of  low-density  lipoprotein  (LDL) 
through  the arterial  endothelium  in  rat aorta and coronary artery, by perfusing in situ native, 
untagged  human, and rat LDL. The latter was rendered electron-opaque after it interacted  with 
the  endothelial  cell  and  was subsequently fixed within  tissue. We  achieved  LDL  electron- 
opacity by an improved fixation procedure  using 3,3'-diaminobenzidine, and mordanting with 
tannic acid. The  unequivocal identification of LDL was implemented  by reacting  immunocy- 
tochemically the perfused  LDL with anti LDL-horseradish  peroxidase conjugate.  Results indicate 
that  LDL  is  taken  up  and  internalized  through  two  parallel  compartmented  routes.  (a)  A 
relatively small amount of LDL is taken  up by endocytosis via: (i) a receptor-mediated  process 
(adsorptive endocytosis)  that involved coated pits/vesicles, and endosomes, and, probably, (ii) 
a receptor-independent process (fluid endocytosis)  carried  out by a fraction of plasmalemmal 
vesicles. Both mechanisms bringing LDL to lysosomes supply cholesterol  to the endothelial cell 
itself.  (b)  Most circulating  LDL  is transported  across the endothelial  cell  by transcytosis  via 
plasmalemmal  vesicles which deliver LDL to the other cells of the vessel wall.  Endocytosis is 
not  enhanced  by  increasing  LDL  concentration,  but  the  receptor-mediated  internalization 
decreases at low temperature.  Transcytosis is less modified by low temperature but is remark- 
ably augmented  at high concentration of LDL. While the endocytosis of homologous  (rat) LDL 
is markedly more pronounced than that of heterologous  (human)  LDL, both types of LDL are 
similarly  transported  by  transcytosis.  These results  indicate  that  the  arterial  endothelium 
possesses a dual mechanism for handling circulating LDL: by a high affinity process, endocytosis 
secures  the  endothelial  cells'  need  for  cholesterol;  by  a  low-affinity  nonsaturable  uptake 
process, transcytosis supplies cholesterol  to the other cells of the vascular wall, and can monitor 
an  excessive accumulation  of  plasma  LDL. Since  in  most  of  our experiments we  used LDL 
concentrations above those found in normal  rats, we presume that at low LDL concentrations 
saturable  high-affinity uptake would be enhanced  in relation to nonsaturable  pathways. 
On a  variety of systems, it has been demonstrated that cells 
acquire cholesterol for membrane synthesis primarily by the 
receptor-mediated uptake  of low-density Lipoprotein (LDL)  1 
which is internalized and delivered to lysosomes. Within the 
Abbreviations  used in this paper:  anti-LDL, rabbit anti-human  LDL 
immunoglobulin;  anti-LDL-HRP, anti-LDL coupled  to horseradish 
peroxidase;  DAB,  3,3'-diaminobenzidine;  HRP,  horseradish  peroxi- 
dase; LDL, low-density lipoprotein;  LDLh, human LDL; LDLr, rat 
LDL; LDS, lipoprotein-deficiem serum; LDL-F, LDL-ferritin conju- 
gate. 
latter, LDL is hydrolyzed and cholesterol is released to be used 
by the cell (6, 8,  12, 16, 23, 24, 65-67). 
To reach various cells, including those of the vessel wall, the 
plasma  LDL  (or  its  components)  has  to  pass  through  the 
vascular endothelium. In vivo, the endothelial cell has a special 
situation since it is faced with the dual problem of taking up 
plasma cholesterol (or LDL) for its own membrane synthesis 
and, at the same time, of transporting LDL or its components 
to the other cells of the surrounding tissue, or of the vessel wall 
itself. In the case of the latter, disturbances in the capability of 
endothelium  to  monitor  the  transport  of  a  physiological 
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within the arterial wall, largely underlie human atherosclerosis. 
The  available  information  indicates  that  the  lipids  and  the 
apoprotein B detected in the atherosclerotic plaque are derived 
mainly from plasma LDL (29,  30,  59).  In both normal and 
atherosclerotic  arteries,  LDL  enters  the  intima  in  relatively 
large amounts (1, 5,  17-21, 29-31, 43, 45, 52, 54, 59-67, 76). 
The  LDL interaction  with  the endothelium  has  been ex- 
plored so far on cultured endothelial ceils (14,  17, 27, 28, 51, 
68, 71,  72).  Very little  is known about such interactions  and 
the routes and mechanisms of LDL transport across endothe- 
lium in vivo (19, 20, 46, 48, 52, 59, 63, 64). 
For visualization of LDL uptake  by different cells,  in the 
procedures  so  far designed,  the particles  were tagged either 
with fluoresceine (4, 36) (for light microscopy), ferritin  (3) or 
coloidal gold (25) (for electron microscopy), or with I2SI,  3H, or 
14C (9,  11, 64) (for radioautography). These labeling methods 
require  chemical treatments  which can modify some of the 
LDL properties. Moreover, the final compound to be taken up 
by the ceil is a  macromolecular complex the components of 
which may differently interact with the endothelial cell. In the 
case of LDL-gold particles, the size of the conjugate (~60 rim) 
drastically  limits  the  uptake  by  plasmalemma  vesicles,  the 
vesicle neck of which is usually -30 nm wide (25). 
Our study's purpose was to investigate in situ the transen- 
dothelial pathway of native untagged LDL particles that, after 
their interaction with the endothelium, were rendered electron- 
opaque by enhancing their contrast or by reacting the bound 
LDL with IgG antiLDL-peroxidase conjugate. 
The major goal of this inquiry was to identify the nature of 
LDL transport across the endothelium in situ.  In addition to 
using rat LDL, we also used human LDL, though the intensity 
of its binding to rat LDL receptors was expected to be much 
lower than that of rat LDL, as indicated by the published data 
on fibroblasts and smooth muscle cells (12,  15, 32, 66). 
The findings reported in this paper indicate that, across the 
arterial  endothelium,  LDL  particles  take  a  dual  pathway 
through two parallel,  compartmented routes: (a) by receptor- 
mediated endocytosis via coated pits/coated vesicles they are 
delivered  to  lysosomes  of the  endothelial  cell,  and  (b)  via 
plasmalemmal  vesicles  they are transported  across the endo- 
thelium to the other components of the vessel wall. 
MATERIALS  AND  METHODS 
Isolation of Lipoproteins 
Since the experiments were carried out mostly in rats, two kinds of LDL were 
isolated: (a) homologous LDL  (from rat  plasma), and  (b)  heterologous LDL 
(from human plasma). 
(a) Rat low-density lipoprotein (LDL) (density [d] =  1.02-1.045  g/ml) was 
separated from pooled rat serum by differential ultracentrifagation (15, 26, 48). 
(b)  Human  low density  lipoprotein (LDL~  (d  =  1.019-1.063  g/m1)  and 
lipoprotein-defieient serum (LDS) (d =  1.225 g/m1) were isolated from fresh 
plasma of healthy subjects by differential ultrac~ntrifugation. The density of 
serum fractions was adjusted by addition of solid KBr. Fractions obtained were 
extensively dialysed against l mM Na2-EDTA in 0.15 NaC1, pH 7.4, at 4°C, for 
72 h (50). 
Characterization of LDL 
NEGATIVE S'gAINING:  LDLparticlesat0.1 mgprotein/ml, after deposition 
on carbon-coated grids, were negatively stained with 1% Na phosphotungstate in 
@1  M  Na phosphate buffer,  pH  7.2,  and examined with a  Phllips 400-HM 
electron microscope (operated as indicated in the section, Electron Microscopy). 
Particle shape and size were measured on 200 free-standing particles on randomly 
collected electron micrographs. 
ENHANCING  LDL  ELECTRON-OPACITV~  Several preparation procedures 
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were  tested for  their capability to impart to  native LDL  particles sufficient 
electron-opacity to render them  directly visible with the electron microscope, 
without additional tagging to a tracer (e.g.,  ferritin or colloidal gold). For this 
purpose, LDL particles were embedded in 4% agarose in Dulbecco's phosphate- 
buffered saline supplemented with I% glucose, and with 0.01 CaCI~ (PBS). Thin 
slices (~50 ~m) of LDL-containing agarose were exposed to various schemes of 
fixation, postftxation, mordanting, and staining in block, then further processed 
for standard Epon embedding, sectioning, and electron microscope examination. 
Controls corlsisted of treating in the same way LDL-ferritin conjugated particles. 
In  the  procedures  employed, the  best  results in  terms of imparting to  LDL 
particles a suitable opacity were obtained by incubating the fixed specimens in 
3,Y-diaminobenzidine (DAB) (LDL fixation procedure worked out by R. Mora, 
A. Nistor, and N. Simionescu, manuscript submitted for publication) followed by 
mordanting the specimens with  1% galloylglucose (tannic acid) (Mallinkrodt, 
Inc., St.  Louis, MO) (56). This procedure was then applied to tissue specimens 
collected from in situ experiments (for details, see Electron Microscopy). By both 
negative and positive staining, LDL size ranged from 18 to 22 nm in diameter. 
LDL  particles were characterized by electrophoretic mobility (40,  46) and 
electrofocusing (75). 2 
POLYACRYLAMIDE ELECTROPHORESIS:  Human LDL and rat LDL were 
delipidated by the method of Brown et al. (7). On examination by PAGE in the 
presence of SDS, the human LDL fraction contained only apoprotein B, whereas 
rat LDL fraction was actually represented by 85-90% apoprotein B and 10-15% 
apoprotein E  (as estimated by densitometric scanning). A  similar pattern was 
earlier reported in the literature (15, 48, 74). 
Protein content was measured by a modified Lowry's method (4 l). Cholesterol 
was determined according to Zak and Zlatkis (see reference 34). 
Conjugation of LDL with Ferritin 
As an additional test for the reliable identification  of contrasted LDL particles 
during their transport across the endothelium, LDL was coupled to ferritin (3, 
35). We estimated the extent of coupling and the number of ferritins bound to 
each LDL particle by negative staining (as indicated for LDL). 
Production of Rabbit Anti-human LDL Antibody 
and Rabbit Anti-rat LDL Antibody and 
Their Conjugates 
PREPARATION:  These two antibodies were obtained by injecting 5-10 mg 
of LDL into female New Zealand rabbits, twice a week for a period 10 weeks (2). 
The rabbit immune sera were purified by DEAE-eelIulose chromatography. 
COUPLING  OF  ANTI-LDL  TO  HRP;  The anti-LDL was conjugated with 
horseradish peroxidase according to the technique of Nakane and Kawaoi (4,*; 
see aLso reference 70). 
TESTS  FOR  PURITY  AND  SPECIFICITY:  The  purity of LDLh  and  the 
specificity  of rabbit anti-human LDL antibody were checked by immunoclectro- 
phoresis (2) and crossed tmmuncclectrophoresis (13). 
The human LDL gave a single precipitin line by immunoelectrophoresis (Fig. 
I a) and a single peak by crossed immuncelectrophoresis vs. horse anti-human 
whole serum (Cantacuzino Institute, Bucharest, Romania) (Fig. I b), or vs. goat 
monospecific anti human lipoprotein serum (Miles Laboratories, Inc., Elkhart, 
IN), or rabbit antihuman LDL serum (Fig. I c). 
The rabbit anti-human LDL antibody gave a single precipitln line vs. human 
serum and none  vs.  HDL  (by immunoelectrophoresis) and a  single peak vs. 
human serum (by crossed immunoclc'ctrophoresLs)  (Fig. ld). The LDL-ferritin 
conjugate (LDL-F)  conjugate gave a  similar precipitin line versus anti-LDL 
antibody as native human LDL. 
By immnnoelectrophoresis, the anti-rat LDL antibody gave a major precipitin 
line vs. rat LDL (d =  1.02-1.045  g/re.l), and a  faint trace against probably rat 
HDL1 present in the fraction isolated at this range of density (Fig. 2). 
The mamunologlcal activity of each anti LDL-horseradish peroxidase (LDL- 
HRP) conjugate was checked by double immunodiffnsion vs. the appropriate 
LDL. The peroxidative activity of the conjugates was tested by incubating the 
immunodiffnsion plate (washed with PBS for 72 h) with DAB in the presence of 
H202. 
Experimental Procedures 
GENERAL CONDITIONS:  The pathway of LDL particles across the endo- 
thelinm of the aorta and coronary artery, in situ, was studied by using, in parallel 
2 The pI of native LDL was found to be 5.4, as compared to pl 5.1 - 5.3 
of the LDL-ferritin conjugate. The latter may reflect the presence of a 
dispersed  population  of LDL  particles produced  by the  coupling of 
one to three ferritin molecules to one LDL. Through the perfusion systems described above, after blood was washed out, 
the following solutions prewarmed at 37°C were sequentially infused: 
(a) 0.2-0A ml of LDLh or LDL~ or 1 ml of LDL-F for time intervals ranging 
from 2 to 10 rain; (b) 2 rain washing with 3-5 ml of PBS (during which, in the 
case of rat experiments, the ligature on the thoracic aorta was loosened); (c) 2% 
glutaraldehyde in 0A M  HCL-Na cacodylate buffer, pH 7.2, for 10 rain. Then, 
small pieces of thoracic and abdominal aorta or coronary artery including their 
adventitia were removed and immersed in the same fixative for 80 rain, and 
further processed for electron microscopy. 
EXPERIMENTS  WITH  ANTI  LDL-HRP:  The purpose of these experiments 
was twofold: to check whether the particles observed in various locations were 
undoubtedly LDL, and to render LDL particles more electron-opaque. After 
perfusion of native LDL or LDL-F (in some controls), and washing out of the 
unbound particles (as indicated above), one of these two protocols was employed: 
(a) perfusion of 0.2-0.4 ml of anti-LDL-HRP (0.1  mg/ml protein content) at 
37°C  for  2  rain  followed  by  washing with  PBS,  and  aldehyde  fLxation  by 
perfusion; (b) after fLxation in situ for 10 min by perfusion of 2% glutaraldehyde, 
small pieces of the aorta and coronary artery were cut and immersed for 20 rain 
in the same fixative. Subsequently, the specimens were processed for immuno- 
cytochemistry. 
Competition Experiments 
To distinguish between high-atTmity and low-affinity binding sites, the inhib- 
itory effect of heparin on LDL binding to its receptor (22) was tested in animals 
which, after receiving LDL or LDL-F at 37°C, were perfused with LDS at 4°C 
for 3 min, followed by heparin (10 mg/ml in 1 ml of LDS) at 4°C for 2 rain. A 
final wash was done with LDS at 4°C and then fixation with glutaraldehyde. 
FIGURE  1  (a)  Immunoelectrophoresis  of  human  serum  (5)  and 
human  LD/  (L)  vs.  horse  anti-human  whole  serum.  (b)  Crossed 
immunoelectrophoresis of human  LDL vs. horse anti-human  whole 
serum. (c) Crossed immunoelectrophoresis of human LDL vs. rabbit 
anti-LDL  serum.  (d)  Crossed  immunoelectrophoresis  of  human 
plasma vs. rabbit  anti-LDL serum. 
experiments, either native untagged particles, untagged LDL subsequently re- 
acted with anti-LDL-HRP or LDL-ferritin conjugate. In male adult R white rats 
of our colony, the serum cholesterol level was found to be ~100 =l= 25 mg/dl, and 
the electrophoretically  B-migrating  hpoproteins were estimated to be ~22 =t: 5 mg 
cholesterol/dL Male adult RAP mice had a serum cholesterol level of ~ 145 rag/ 
dl,  and electrophoretically B-migrating hpoprotein of ~30 mg cholesterol/dl. 
Since a broad range of plasma LDL level, sometimes threefold ranges in the same 
rat strain (e.g., Sprague-Dawley animals), has been reported in the literature (3, 
10, 12, 20, 39, 42, 49, 53, 55), we calculated the LDL concentrations used in our 
experiments on the basis of the values detected in this strain of rats. Actually, the 
concentration found (22 rag LDL cholesterol/dl), falls within the range reported 
in the literature (from 16 to 50 mg LDL cholesterol/all serum) (12), and is close 
to that most frequently reported in the literature (15 mg cholesterol/dl serum 
[12]).  Both  kinds  of LDL,  homologous and  heterologous, were  used  at  the 
following concentrations: (a) physiological concentrations: 10 and 30 mg LDL 
cholesterol/dl; and (b) high concentrations: 80, 170, and 220 mg LDL cholesterol/ 
dL Experiments were carried out at 37°C; in some experiments, the perfusion 
solutions used were at 4°C. The actual time intervals from LDL administration 
until fixation in situ ranged from 2 to 10 nun. The shortest time interval (2 rain) 
included the time required for LDL injection, and the washing of unbound LDL 
with perfusion of PBS or lipoprotein-deficient serum (LDS). 
EXPERIMENTS  WITH  LDL AND  LDL-F:  35 male adult R white rats and 15 
male adult RAP mice kept in standard housing conditions were fasted for 24 h 
before experiment. Animals were anesthetized with chloral hydrate 50 rag/100 g 
body weight (mice) or diethyllc ether (rats). The vascular bed was cleared of 
blood by perfusion with a  Harvard pump with PBS supplemented with 0.25% 
glucose, at 37°C. Depending on the  artery under investigation, the peffusion 
procedure used for both washing out the blood and the administration of LDL 
was different. In rat, for both the aorta and the coronary artery, perfusion with 
PBS was done through the thoracic cava, using the abdominal cava as outlet. 
Then, for peffusing LDL, the thoracic aorta was tightly llgated and a free needle 
was introduced into the  left ventricle. The  latter route was used also for the 
administration of the subsequent solutions (e.g, PBS,  fixative). In mouse, the 
perfusion system employed the abdominal aorta as inlet, and abdominal cava as 
outlet. 
Controls 
(a) To check whether some of the visualized LDL is endogenous rat LDL that 
was being taken up at the time the animal was killed, in some rats, after 5-rain 
perfusion with PBS and not receiving LDL, the specimens were fixed in alde- 
hydes, incubated with DAB. H~Oe and further processed according to the same 
preparation procedure used for electron microscopy and immunocytochemistry. 
(b) Control experiments consisted in perfnsing--instead of LDL or LDL-F-- 
either native ferritin or activated ferritin (0.1-0.6 mg/ml protein content) at 37°C, 
for periods of 2-10 rain. 
(c) In another series of controls, anti-LDL-HRP (0.1  mg/ml protein content) 
or HRP alone was infused, the rest of the procedure being foLlowed as described. 
(d) The possible effect of the presence or absence of proteins in the perfusion 
media was tested by infusing the vascular bed with either (a) PBS followed by 
LDL, and washing with PBS; (b) PBS with LDS followed by LDL, and washing 
with PBS +  LDS, or (c) LDS followed by LDL, washed thereafter with LDS. 
Llectron /vl~croscopy 
From experiments with LDL, LDL-F, and some controls, small pieces of the 
thoracic  and  abdominal  aorta,  and  coronary artery,  fLxed  in  situ  with  2% 
glutaraldehyde, were removed and immersed for 80 rain in the same fixative, 
followed by incubation with 0.15% DAB in 0.06 M  HCI-Tris buffer, pH 8.0, for 
30  min  at  23°C.  After  brief washing in  cacodylate buffer,  specimens  were 
postftxed with 2% OsO4 in 0.1  M HC1-Na cacodylate buffer, pH 7.2, at 4°C, for 
90 rain, followed by in-block staining with 0.5% aqueous uranyl acetate for 30 
rain at 2°C, or by mordanting with 1% tannic acid as previously described (56) 
(see  Fig.  3c).  Tissue  processing was  completed  by  standard  procedure  for 
dehydration and Epon embedding. Thin sections cut with an American Optical 
Ultracut  (American  Optical  Scientific Instruments,  Buffalo, NY)  or  Richert 
ultramicrotome (Richert Spring Corp., Pittsburgh, PA) were stained with lead 
citrate and examined with a Phihps 400-HM electron microscope, operated at 80 
kV. 
Immunocytochemistry 
From experiments with anti LDL-HRP (60), and their pertinent controls, after 
fixation  in  situ,  small pieces  of the  aorta and coronary artery were cut and 
processed through one of the following methods: (a) Immersion in 2% glutaral- 
dehyde in 0.1  M  HCI-Na cacudylate buffer, pH 7.2, for 80 mitt, at 23°C; then 
incubation in 0.15% DAB in 0.06 M  Tris-HC1, pH 8.0, and 0.02% H202, for 60 
min at 37°C. After brief washing in buffer, fixation in 2% OsO4, and further 
preparation for electron microscopy  by the standard procedure. (b) Immersion in 
the aldehyde fixative as in a  for 10--20 rain. After a  brief wash with PBS, the 
specimens were embedded in 5% agarose in PBS, and thin slabs (~50/.tin thick) 
were sectioned with a  Smith-Farquhar chopper. Sections were incubated with 
anti LDL-HRP (0.1 mg/ml protein content) for 40 rain, washed with buffer for 
15 rain, then fixed with 2% glutaraldehyde for 60 min. The peroxidatic reaction 
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in Spurt resin (62). 
RESULTS 
Visualization of LDL Particles 
Freshly isolated native LDL could be directly visualized as 
spherical  ~20-nm diameter particles,  especially in well-fixed 
specimens  that  were  treated  in-block  with  galloylglucose 
(tannic acid) or uranyl acetate. The electron density was par- 
ticularly enhanced by reacting LDL with anti-LDL-HRP. The 
reaction product of the latter slightly increased the overall size 
of the  conjugate  which  frequently  appeared  less  spherical, 
FIGURE  2  Gel chromatography of the crude anti human LDL-HRP 
conjugate (6 mg anti-LDL tgG conjugated with 5 mg HRP),  on a 1.5 
X  85  cm  column  of  Sephadex  G200  eluted  with  PBS. Double 
immunodiffusion of aliquots (40/~m) from peak I vs. LDLu, indicated 
that  the  anti-LDL-HRP  conjugate  elutes  in  fractions  35-50  which 
had  peroxidatic activity. These fractions  were used for the experi- 
ments.  All  electron  micrographs  represent  aortic endothelium  of 
rats infused with  human LDL (10 mg LDL cholesterol/dl). 
rather polymorphic (Fig. 3). When anti-LDL-HRP was applied 
to sections, it could reach accessible LDL particles in various 
locations. Anti-LDL-HRP perfused in situ had access only to 
LDL particles found on the cell surface or within open vesicles. 
Occasionally, the  antigen-antibody complex continued to be 
internalized and eventually detected deep in the endothelium. 
In similar experimental conditions, the number of LDL parti- 
cles observed in various locations was comparable, irrespective 
of the visualization technique used. However, a slightly higher 
number of  LDL was recorded when rabbit anti-LDL antiserum 
was used, presumably due to a stabilizing effect of  the latter on 
the LDL apoprotein. The findings reported from this point on 
are based primarily on the experiments in which human and 
rat LDL were immunocytochemically detected. 
GENERAL 
In  animals  perfused  with  PBS  and  not  given  LDL,  but 
infused with anti-rat LDL-HRP, no lipoprotein particles were 
detected on the endothelium or within its vesicles.  This indi- 
cates  that  after  5-rain  perfusion  with  PBS,  the  endogenous 
LDL occurring at the level of endothelium has been practically 
removed. 
The findings showed that, at 37°C, physiological concentra- 
tions  of homologous or heterologous  LDL (10--30  mg LDL 
cholesterol/all of perfusate) interact with the arterial endothe- 
lium in situ in a stepwise process. This consists of LDL binding 
to the endothelial surface with subsequent internalization fol- 
lowed either by degradation within the endothelial cell (endo- 
cytosis) (Figs. 4-10) or by their transport across the endothe- 
lium to the  subendothelial  space (transcytosis) (Figs.  11-20). 
This  dual  pathway  involves  two  separate  compartmented 
routes which have a similar pattern in the endothelium of the 
arteries  examined  (aorta,  coronary) as well  as  in  their  vasa 
vasorum (69). 
As expected, as compared to rat LDL, human LDL bound 
less extensively to rat LDL receptors. However, because of the 
known homogeneity of the human LDL fraction (15,  26, 48), 
the  quantitative  work  was  done  with  human  LDL.  The 
emerged figures, though considered underestimates, have been 
used as relative values which may reflect the nature and some 
particulars of the process, and not its absolute magnitude. The 
FIGURE  3  Various methods used for in situ visualization of human LDL during its interaction with the arterial endothelium: (a) 
LDL-ferritin  conjugate  (no additional contrasting);  (b)  LDL-ferritin  conjugate, with  additional contrasting  by mordanting with 
tannic acid; (c) native, untagged LDL fixed with the glutaraldehyde and DAB procedure and contrasted by mordanting with tannic 
acid; and (d))  native, untagged LDL reacted with anti LDL-HRP conjugate. (a) x  110,000;  (b)  x  94,000;  (c)  x  86,000;  (d) X 80,000. 
1680  THE  JOURNAL OF  CELL BIOLOGY • VOLUME 96, 1983 FIGURES 4-10  Gallery  of  electron  micrographs  illustrating  the  sequential  steps  of  endocytosis  of  human  LDL  (10  mg  LDL 
cholesterol/dl)  in the rat endothelium as detected by immunocytochemistry.  For all micrographs:  1, lumen;  e, endothelium;  ss, 
subendothelial space;  v, plasmalemmal vesicle;  cp,  coated pit;  cv,  coated vesicle;  p, pinosome (endosome);  my,  multivesicular 
body;  ly,  lysosome; and  c, collagen. Fig. 4:2  min after perfusion.  LDL  particles, either isolated or in small clusters, are bound to 
smooth regions (arrow) or coated regions (arrowhead) of the luminal front of the endothelial cell  membrane, x  80,000.  Fig. 5:2 
min  after  perfusion.  Occasionally, small  clusters  of  LDL  are also bound  to  indentations of cell  surface  devoid  of conspicuous 
coating (arrow). x  84,000.  Fig. 6:2 min after perfusion. LDL marks some coated pits X 72,000.  Fig. 7: Formation of a coated vesicle 
labeled  by  an  LDL  particle  (arrowhead)  while  two  other  LDL  particles  appear bound  to  the  neighboring  plasma  membrane 
(arrows). x  70,000.  Fig. 8:5 min after perfusion. LDL (arrowhead) marks some large uncoated vesicles (pinosomes). x  70,000.  Fig. 
9:5 min after perfusion. Occasionally, LDL (arrowhead) can be detected within  multivesicular bodies, x  94,000.  Fig. 10:5 min  (as 
well as 10 rain) after perfusion. LDL (arrowhead) could be detected within lysosomes, x  72,000. 
VAS[LE ET AL.  Lipoprotein in the Arterial Endothelium  1681 1682  THE JOURNAL OF CELL  BIOLOGY. VOLUME  96, 1983 FIGURE 20  Rat aortic endothelium, 5 min after perfusion of human LDL (10 mg LDL cholesterol/d0. LDL (arrowheads) could be 
concomitantly detected  in  features involved  in  endocytosis: e.g.,  pinosome  (endosome)  (p),  and  lysosome (/y),  as well  as  in 
features involved in transcytosis: e.g., plasmalemmal vesicles (v) open on the abluminal front of the endothelial cell x  86,000. 
observations with homologous LDL were not quantitated be- 
cause  rat  LDL fraction contains  about  15%  HDL1 particles 
which cannot be distinguished from the LDL particles. Within 
these reservations, it can be stated that as a general pattern of 
the process the binding and uptake of rat LDL by endocytosis 
appeared qualitatively significantly greater than that of  human 
LDL; this difference was inconspicuous in the case of transcy- 
tosis (see the detailed Results). 
At high concentrations of either rat or human LDL (80--220 
mg LDL cholesterol/dl  of perfusate),  while  endocytosis was 
not obviously augmented, transcytosis did parallel the increase 
in LDL concentration in the vascular lumen. 
FIGURES 11-19  Gallery  of  electron  micrographs  illustrating  sequential  steps  of  LDL  transcytosis  of  human  LDL  (10  mg  LDL 
cholesterol/dl)  through  rat aortic endothelium, as detected  by immunocytochemistry.  Fig.  11:2  rain after perfusion.  Some LDL 
particles  (arrowhead) are bound to smooth areas of the luminal front of endothelial plasma membrane, x  86,000.  Fig.  12:2  min 
after  perfusion.  LDL  particles  (arrowheads)  are  also encountered  close  to  the  vesicle openings,  x  88,000.  Fig.  13:2  min  after 
perfusion. While some LDL particles occur on the endothelial cell surface (arrow), other particles (arrowhead) mark plasmalemmal 
vesicles (v)  associated with  the luminal front,  j, intercellular junction,  x  98,000.  Fig.  14:5  rain after perfusion.  LDL  (arrowhead) 
marked plasmalemmal vesicles located inside the cytoplasm, x  85,000.  Fig. 15:5 rain after perfusion. LDL (arrowhead) could also 
be detected within  plasmalemmal vesicles associated with the abluminal part of the intercellular spaces (arrow). x  80,000.  Fig. 16: 
5 min after perfusion. LDL (arrowhead) marked some plasmalemmal vesicles open on the abluminal front of the endothelial cell. 
x  72,000.  Fig. 17:5 rain after perfusion. LDL (arrowheads) occurred as apparently intact particles within the subendothelial space 
(ss). x  78,000.  Fig. 18:5 min after perfusion. LDL (arrowheads) could also be encountered within the subendothelial space, against 
the basal lamina (b/) and internal elastica (ie). x  78,000. Fig. 19:10 rain after perfusion. In some locations the immunocytochemical 
reaction revealed relatively small particles (arrowhead), presumably representing partially degraded LDL or fragments of apoprotein 
B. x  84,000. 
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Physiologic Concentrations of LDL  (10-30 mg 
LDL Cholesterol/dO 
EARLY  EVENTS:  UP  TO  2  MIN:  Human LDL: from the 
earliest  time  points  investigated,  LDLh particles  were found 
bound  to the  luminal  endothelial  plasmalemma  (apparently 
smooth areas) (Figs. 4, 5, and  11), on coated pits (Figs. 4 and 
6),  facing the  vesicle stomata (Fig.  12), or occurring within 
plasmalemmal vesicles open on the luminal front. In incom- 
pletely washed specimens, unbound LDL particles could also 
be  observed  in  the  vascular  lumen.  The  number  of LDL 
particles bound to the endothelial cell surface varied largely 
from one region to another of the endothelium, being relatively 
higher in the coronary artery than in the aorta. In most cases, 
one to three LDL particles were observed attached to coated 
pits (Figs. 4 and 6); only -50% of coated pits were marked by 
detectable  LDL.  The  numerical  density  of LDL  bound  on 
coated  pits  was  estimated  at  5  to  8  LDL particles/van  2 of 
endothelial  surface  (see  legends to Figs.  21  and  22).  In the 
same specimens, the average number of LDL found on smooth 
regions  of plasma  membrane,  vesicle  stomata  and  luminal 
plasmalemmal  vesicles was  13-14 LDL particles/~m ~ of en- 
dothelial surface. 
Rat LDL: In general, the binding values for LDLr particles 
(which reportedly contains -15% HDL  0  were about twofold 
higher than  for human LDL. The most characteristic differ- 
ences observed was a higher number of LDLr particles (two to 
five) bound to a coated pit, and an increased number of coated 
pits (-80-85%) which were marked by LD~ particles at this 
early time point. 
LATE  EVENTS:  UP  TO  10  MIN:  In both LDLh and LDLr 
experiments, the extension of the time interval to 10 min after 
LDL perfusion (Fig, 21, for LDLh) resulted in 50-60% decrease 
in the frequency of coated pits and regions of plasmalemma 
marked by LDL: concomitantly, augmentation of LDL label- 
ing of endosomes, lysosomes and internalized  plasmalemmal 
vesicles  occurred (Fig. 21). 
High Concentrations of LDL  (80-220 
me, LDL Cholesterol/d 0 
When high concentrations of either human LDL or rat LDL 
were  employed,  the  labeling  of coated  pits  did  not  change 
significantly. At 5-min time interval, however, the number of 
LDLh or  LDLr  bound  to  plasmalemma  or  associated  with 
vesicle stomata was decreased by ~35-40% (as compared to 
low LDL concentrations) with concomitant augmentation of 
the number of LDL particles  internalized  by plasmalemmal 
vesicles  (Fig.  22).  The binding values  were not significantly 
changed by perfusing LDLh or LDLr solutions at 4°C. 
Heparin was able to displace most of LDL from coated pits 
and  plasma  membrane,  but  only slightly  reduced  the  LDL 
uptake  by plasmalemmal  vesicles.  These  results  were  inter- 
preted as a suggestion for the existence on the endothelial cell 
surface of  two types of LDL-binding sites: high-affinity binding 
sites (coated pits) and probably low-affinity binding sites (plas- 
malemmal vesicles). 
LDL  INTERNALIZATION 
Physiologic Concentrations of LDL 
The kinetics of various endothelial features involved in the 
LDL transport indicated that, over time intervals ranging from 
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FIGURE 21  Kinetics  of  human  LDL  endocytosis  and  transcytosis 
through  rat arterial  endothelium,  as a function  of time.  The  LDL 
concentration employed in these pulse-chase experiments was 10- 
30 mg LDL cholesterol/100 ml. Features involved in receptor-medi- 
ated endocytosis: cp, coated pit;  e, endosome (pinosome); and ly, 
lysosome. Features  involved in transcytosis (and possibly in recep- 
tor-independent endocytosis):  pro, plasma membrane;  vi, vesicle 
infundibulum; pvl,  plasmalemmal vesicle open on the luminal front; 
pvi, plasmalemmal vesicle located inside the cytoplasm; pv~,  plas- 
ma[emmal vesicle associated with  or open on the abluminal front 
of the endothelium; and  ss, subendothelial space.  For each  time 
point, 10 to 13 animals were used and from each animal four to six 
aortic  and  coronary specimens were collected  and  processed for 
electron  microscopy.  From  each  specimen, we examined 60 to 80 
sections, and carried out the measurements on the following total 
length of endothelial profiles: 410 #m, 422/~m,and 478 #m for 2, 5, 
and  10  rain,  respectively. The  number of  particles in  the various 
locations, counted on randomly collected specimens, were 707 for 
2  min,  682  for  5  rain,  and  728  for  10  rain.  From  the  linear data 
regarding LDL binding to the cell surface,  the endothelial surface 
was calculated by considering a section thickness of ~60 nm. SD of 
the mean, determined  by using large sample theory,  ranged from 
±23 to ±47. 
2 to l0 rain, LDL was transported through arterial endothelium 
via two compartmented pathways by endocytosis and transcy- 
tosis.  Receptor-mediated endocytosis of rat  LDL was signif- 
icantly  more pronounced  than  that  of human  LDL,  as  ex- 
pressed by a higher number (almost double) of coated vesicles, 
endosomes and lysosomes marked by LDL~ as compared to 
LDLb. Conversely, the extent of LDL internalization by trans- 
cytosis (via plasmalemmal  vesicles)  did not markedly differ 
between human LDL and rat LDL. 
ENDOCYTOSIS:  As indicated  by the time  course experi- 
ments ranging from 2 to 10 rain, receptor-mediated endocytosis 
involved successively coated pits (Figs. 4 and 6), coated vesicles 
(Fig. 7), most frequently large, -10-15 nm diameter, uncoated 
vesicles (endosomes or pinosomes) (Fig. 8) (63), 3 multivesicular 
bodies  (Fig.  9),  and  secondary  lysosomes.  It  could  not  be 
distinguished whether, in addition to this characteristic recep- 
tor-mediated uptake (3, 6, 23, 24), a certain fraction of LDL- 
labeled plasmalemmal vesicles were destined for lysosomes as 
well, by a receptor-independent mechanism. Within lysosomes, 
totally, or what appeared to be partially, intact LDL particles 
were detected (Figs. 10 and 20). 
TRANSCYTOSIS:  A  relatively large number of either hu- 
man  LDL  or  rat  LDL  particles  was  taken  up  by  discrete 
plasmalemmal vesicles open on the luminal aspect of endothe- 
lium. Up to 5 rain, most of  these LDL-labeled vesicles appeared 
internalized (Figs. 12-15),  some of them approaching (Fig. 15) 
s Because the visualization of  the vesicle "coat" is sometimes uncertain, 
we used also in this paper the term "pinosome" (73) as alternative to 
"endosome" to define uncoated vesicles or vacuoles of-10-15 nm 
diameter, which appear to be instrumental in receptor-mediated en- 
docytosis. -~  % 
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FIGURE 22  Kinetics  of  human  LDL  endocytosis  and  transcytosis 
across rat arterial endothelium,  as a function  of LDL concentration. 
The time  point examined:  5  min.  For legend  to abbreviations and 
other  data,  see  Fig.  21.  Specimen  sampling:  for  10-30  mg  LDL 
cholesterol/100  ml,  as  indicated  in  Fig.  21;  for  170-220  mg  LDL 
cholesterol/100 ml, the total length of endothelial profiles examined 
was 306/xm, and the number of LDL particles counted was 486. 
or discharging their content into the subendothelial space (Figs. 
16 and 20). We observed no remarkable difference in the rate 
of transcytosis between  human  LDL  and  rat  LDL.  In  the 
conditions of our experiments, the number of plasmalemmal 
vesicles marked by LDL particles was augmented by the in- 
creasing time interval (Fig. 23), but was much less or not at all 
influenced by lowering to 4°C the temperature of the infused 
solutions. 
High Concentrations of LDL 
ENDOCYTOSIS:  The  receptor-mediated uptake  of either 
human LDL or rat LDL seemed not significantly augmented 
either by increasing several-fold (4- to 10-fold) the LDL con- 
centration in the perfusate or by extending the time interval of 
the endothelial cell exposure to LDL. The efficiency of endo- 
cytic pathway appeared, however, diminished by low temper- 
ature. 
TRANSCYTOSIS:  The  transendothelial transport of both 
human  LDL  and  rat  LDL  by  plasmalemmal  vesicles was 
augmented with both the increasing LDL time interval (Fig. 
23)  concentration (Fig. 24).  This process was virtually unaf- 
fected by lowering the temperature of the infused solutions to 
4°C. 
In none of the experimental conditions used was either LDLh 
or LDL~ observed passing through the intercellular junctions 
of arterial endothelium. 
LDL  IN  THE  SUBENDOTHELIAL  SPACE 
Physiologic Concentrations of LDL 
When concentrations of LDL in the range of 10-30 mg LDL 
cholesterol/dl were  perfused,  at  2  to  5  min,  LDL  particles 
detectable within  the  subendothelial spaces  were  extremely 
rare. At 5-10 min; few LDL particles could be visulized within 
the subendothelial space against the basal lamina (Figs.  17- 
19),  or beyond the  latter.  The  number  of apparently intact 
LDL observed in the subendothelial space was usually much 
smaller than the amount of LDL which, at earlier time points, 
was bound  to the  endothelial surface or internalized within 
plasmalemmal vesicles. 
High Concentrations of LDL 
In experiments in which  the perfusion solution contained 
80--220  mg  LDL  cholesterol/dl, although  the LDL particles 
visualized in  the  subendothelial space  were  more  frequent, 
their average number was much lower than that recorded, at 
earlier time points, bound to the endothelial cell surface (Figs. 
21  and  22).  We  observed  no  significant  difference  in  the 
frequency of human  LDL or rat LDL in the subendothelial 
space. 
In areas lacking endothelium (accidentally damaged during 
perfusion maneuvers), neither LDLh nor LD~ accumulated in 
the local subendothelium. LDL particles were encountered in 
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FIGURE 23  Histogram  depicting  the  numerical  density  of  human 
LDL//~m 2 of endothelial  section  as a  function  of time  in  rats  that 
have received 10-30 mg of LDL cholesterol per 100 ml of perfusate. 
Vertical  bars represent the SD of the mean estimated  by the large 
sample  theory  method.  Features  involved  in  receptor-mediated 
endocytosis  are:  coated  pits,  coated  vesicles,  endosomes  (pino- 
somes),  lysosomes.  Features involved  in  transcytosis  and,  possibly 
to a lesser extent, in receptor-independent endocytosis are: plasma 
membrane,  vesicle  infundibulum,  p[asmalemmal  vesicles.  Because 
these structures are located at various depths within the endothelial 
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FIGURE 24  Histogram  showing  the  numerical  density  of  human 
LDL per ~m 2 of endothelial  profile (rat aorta), as a function  of LDL 
concentration.  For other data, see legend to Fig. 22. 
VAS~LE [T  AL.  Lipoprotein  in the Arterial Endothelium  1685 The interaction of LDL with other components of the arterial 
wall (smooth muscle cells,  elastic lamellae, collagens, ground 
substance, etc.) will be reported in a forthcoming paper. 
Under some peculiarities,  the LDL pathway across the en- 
dothelium of vasa vasorum occurs in a fashion similar to that 
observed in the arterial endothelium (69) (manuscript in prep- 
aration). 
Con trois 
In animals  perfused with  either native ferritin  (pI 4.5)  or 
glutaraldehyde-activated ferritin (pI 4.4 - 4.6),  none of these 
tracers was found in a significant amount on coated pits or in 
coated  vesicles.  Negative  results  were  also  recorded  in  the 
experiments in which either HRP or DAB alone was intravas- 
cularly injected. 
In the  presence  of proteins  (brought  in  by  LDS)  in  the 
perfusion media, the LDL uptake by the endotbelium appeared 
significantly reduced  as compared to  animals  perfused with 
LDL in PBS only. 
DISCUSSION 
The points to be discussed are related to the methodology used, 
and the results obtained and their possible interpretation. 
Visualization  of Untagged LDL 
The investigation of LDL interaction with the vascular en- 
dothelium by using the system presented in this paper has the 
advantage of an in situ  study employing fresh, negative un- 
tagged LDL, rendered visible after its interaction with the cell 
and subsequent fixation within tissues.  The techniques previ- 
ously developed by other investigators to make LDL ultrastruc- 
tural  probes  by tagging  an  electron-opaque  tracer  (ferritin, 
colloidal gold) require extensive chemical treatment,  repurifi- 
cation of the labeled product, etc., procedures which can mod- 
ify  LDL  reactivity.  Moreover,  in  the  case  of LDL-ferritin 
conjugate (3), only the ferritin core can be visualized and one 
has to assume that each core is backed by an LDL. Colloidal 
gold-LDL conjugate, due to its large size (~60 nm), severely 
limits its uptake by pinocytic or plasmalemmal vesicles (25), 
thus becoming unsuitable for studies on LDL transport by such 
structures. In addition, the LDL-ferritin and LDL-gold conju- 
gates interact  with  target cells as combined macromolecular 
complexes, and not strictly as LDL particles. 
The omission of the chemical treatments  required  by any 
labeling secures a better preservation of LDL particles which 
facilitates the contrasting procedures designed to enhance LDL 
electron  opacity.  The  LDL preservation  can  be  further  im- 
proved by addition of LDS, by supplementing the fixative with 
DAB  (that  increases  the  cross-linking),  and  by mordanting 
with tannic acid, which, in addition to enhancing contrast, also 
prevents  extensive  extraction  during  specimen  dehydration 
(56). 
The immunocytochemical reaction of LDL by anti  LDL- 
HRP allows the unequivocal identification of LDL particles, 
with concomitant enhancement of  their electron opacity. Since, 
in the case of LDL, the immunocytochemical procedure detects 
individual particles, the technique has less limitations than the 
cytochemical methods in which the t'mal mass reaction product 
does not allow any quantification. 
Human LDL and Rat LDL 
It has been shown that, at least in culture conditions, haman 
LDL binds rather poorly to rat LDL receptors in fibroblasts 
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and smooth muscle ceils (12,  15, 32, 66). In other experimental 
conditions, however, an increased binding of human LDL to 
liver membranes from rats treated with  17-a-ethinyl estradiol 
(37), and a hepatic catabolism of human LDL similar to that 
of rat  LDL in  intact  rats  (55)  and  in  the  rats  treated  with 
estradiol  (10,  74),  were  reported.  Similar  observations  have 
been made in other species,  e.g., a comparable hepatic catab- 
olism  of intravenously  administered  human  or  canine  E2~I- 
labeled  LDL, in dog, despite different apparent affinities for 
receptors (38). In recent work by Pittman et al. (48), on tissue 
sites of catabolism of rat and human LDL in rats, it has been 
pointed out that,  despite the low affmity of human LDL for 
rat  LDL receptors,  human  and  rat  LDL are  catabolized  at 
similar rates and at similar sites.  A well-founded explanation 
of such apparent discrepancies has not been yet produced. 
As far as we know, there is no reported information on the 
distribution and cellular localization of LDL receptors of the 
endothelial  cell in situ.  In our experiments,  we used  human 
LDL because it is a homogeneous fraction containing almost 
exclusively apolipoprotein B. Human LDL, although at a lower 
rate,  can reveal LDL-binding sites  exclusively.  As such,  the 
high-affinity uptake detected in the LDLh experiments should 
be  considered underestimated.  The  data  that  emerged  from 
these experiments have been used as relative values which may 
reflect the nature and not the absolute magnitude of  the process 
observed.  The rat LDL used in parallel experiments  has the 
advantage oftbe homologus high binding to rat LDL receptors 
but  has  the disadvantage  of being a  heterogeneous  fraction 
which contains small but defmite amounts of apohpoprotein E 
(10-15% of LDL protein). This suggests that the binding sites 
and pathways detected with rat LDL reflect, to some degree, 
the sites  for uptake and routes for transport of HDL~ as well. 
Accordingly, no quantitation was made for the results obtained 
with rat LDL. 
Physiologic vs. High Concentration of LDL 
In the male adult R white rats used in our experiments, the 
serum level of LDL cholesterol was found to he ~22 mg/dl. In 
the literature,  a surprisingly broad spectrum of LDL concen- 
trations  has  been  reported;  the  difference  occurs  not  only 
between  various  strains  of rats  but  in  animals  of the  same 
strain.  For  example,  in  fed,  male  Sprague-Dawley  rats,  a 
threefold  range  in  both  LDL  and  HDL levels  is  apparent. 
These discrepancies are difficult to explain entirely (12). In the 
strains of rats used in the last decade by many investigators, 
the LDL cholesterol had values of 10-15 mg/dl. As described 
above, the LDL cholesterol concentrations used in some of our 
experiments  were  in  the  range  of 10  mg/dl  or close to  the 
physiological range (30 mg/di). The LDL cholesterol concen- 
trations (80-220 mg/dl) used in other experiments were well 
above the normal physiological range. 
Results in General: the LDL Dual Pathway 
The  methodology used  in  this  study to investigate  LDL 
interaction with vascular endothelium in situ was that generally 
applied  to trace the intracellular pathway(s) taken by water- 
soluble  macromolecules across epithelia  and  endothelia.  On 
such studies involving pulse-chase experiments carried out at 
successive time intervals and electron micrographic recording 
of the cellular events on large sampling is largely based our 
current knowledge on the cellular aspects of transendothehal 
passage of macromolecules (47). 
Results  obtained  in  these  experiments,  as  well  as  those previously reported (69),  indicate that LDL enters the vessel 
wall from both faces: the luminal endothelium and the endo- 
thelium of the vasa vasorum. During its passage through the 
endothelinm, LDL behaves as a water-soluble macromolecule 
and  is carried  across  the endothelial  cell by two  commonly 
involved basic processes, namely receptor-mediated endocyto- 
sis (coated pits/vesicles,  endosomes, lysosomes) and transcel- 
lular passage or transcytosis (57, 58) (plasmmalemmal vesicles). 
Both  processes  occur  simultaneously;  the  distinction  be- 
tween them is based mostly on: (a) successive LDL labeling of 
the  structures  participating  in receptor-mediated  endocytosis 
(coated pits,  endosomes, lysosomes), (b) progressive LDL la- 
beling of plasmalemmal vesicles from the luminal front to the 
abluminal front with the occurrence on the latter (at later time 
points) of LDL within vesicles open and apparently discharging 
their content, and (c) the appearance,  at later time points, of 
LDL in the subendothelial space, where it increases in amount 
with time and concentration. 
This LDL dual pathway across the vascular endothelium has 
to be expected in view of the fact that endothelial cell in situ 
is a special cell different from all other cells in which the "LDL 
pathway" has been investigated, mostly in culture (e.g., fibro- 
blast, macrophage, smooth muscle cells).  The endothelial cell 
needs plasma LDL cholesterol for its own membrane synthesis 
and, at the same time, has to transport LDL or its components 
to the other cells of the surrounding tissue,  including those of 
the vessel wall itself.  The latter process could not be detected 
in endothelial cells in culture (61) because of the loss of their 
functional polarity and the absence of concentration gradients 
across the cell. In vivo, the fibroblasts and smooth muscle cells 
can actually recognize and metabolize LDL particles, provided 
these  particles have been transported  across endothelium by 
transcytosis  from the  plasma  into  the  interstitial  fluid.  The 
demonstration of the way in which, in vivo, the fibroblast and 
other cells are handling the LDL which was previously trans- 
ported through endothelium may largely enhance the physio- 
logical significance of the LDL pathway identified in such cells 
so far in in vitro conditions only. 
Endocytosis 
As indicated by the kinetics of LDL labeling of the endothe- 
lial features involved in endocytosis, at physiologic concentra- 
tions  of LDL,  some  particles  are  taken  up  by  a  receptor- 
mediated process in which, at early time points (2 min), LDL 
particles are bound to coated pits and then appear internalized 
in  coated  vesicles,  endosomes  and,  starting  at  5  min,  LDL 
could be detected in multivesicular bodies and lysosomes. The 
process is similar to the LDL pathway originally described in 
fibroblasts in culture  (3,  23,  24).  Since heparin almost com- 
pletely displaced LDL from coated pits, these features behave 
in the endothelial cell as well as high-affinity binding sites.  It 
cannot be distinguished whether some LDL particles are also 
taken up by a receptor-independent process (fluid endocytosis) 
presumably carried out by a small fraction of plasmalemmal 
vesicles.  Based  on  observations  with  other  macromolecular 
tracers, this may be a remote possibility since, during transport 
of solutes by plasmalemmal vesicles,  commonly these shortcut 
the lysosomal compartment (47, 57, 58). There is no evidence 
on whether all LDL-labeled coated vesicles or endosomes reach 
the lysosomes or whether all the LDL taken in by plasmalem- 
mal  vesicles is  transported  across the  cell.  In the conditions 
used  in  our  experiments,  the  endocytosis of LDL  does  not 
parallel the increase in LDL concentration (up to 220 mg LDL 
cholesterol/dl) in the vascular lumen. This suggests that in vivo 
the  high-affinity binding  sites  on the  luminal  aspect  of the 
endothelium  are  probably  fully  saturated  by  relatively  low 
concentrations of LDL such as 10-30 mg LDL cholesterol/dl. 
The low temperature  (4°C) remarkably inhibits the LDL in- 
ternalization by a receptor-mediated process. Rat LDL is taken 
up by endocytosis more avidly than human LDL: the average 
number of LDL particles bound to coated pits is almost double 
(two  to five) that  observed for LDLh (one to two); and  the 
percentage of coated pits marked by LDL is almost 80-85% in 
the case of LD~ as compared to LDLh in which this value is 
approximately 45-50%. 
Transcytosis 
At physiologic concentrations (10-30 mg LDL cholesterol/ 
dl), LDL particles are also taken up by plasmalemmal vesicles. 
At early time  points  (up to 2  rain),  LDL can be  visualized 
within such vesicles which are associated with the luminal front 
or which are apparently free in the cytoplasm. At later time 
points (5 rain), more LDL-labeled vesicles can be seen on the 
tissue front of the endothelium and in the subendothelial space. 
This process was significantly augmented when high concen- 
trations of LDL (up to 220 nag cholesterol/dl) were perfused. 
Since heparin only slightly reduced the LDL uptake by plas- 
malemmal vesicles, these features can be tentatively considered 
low-affinity sites. (However, the possibility that failure of hep- 
arin to displace LDL from plasmalemmal vesicles is due not to 
low-affinity sites  but to mechanical factors--or both--cannot 
be ruled out.) The characterization of other parameters of these 
endothelial  sites  of presumably  different  affinities  for LDL 
remains to be worked out, including experiments with meth- 
ylated LDL (6). Transcytosis of LDL appears not to be signif- 
icantly modified  by low temperature.  Human  LDL and  rat 
LDL are transported at similar rates which appear to be simply 
proportional to the LDL concentration in the perfusion me- 
dium.  LDL transcytosis appears to be a nonsaturable uptake 
process that  does not discriminate  between homologous and 
heterologous LDL. Exposure of endothelium to higher concen- 
trations of LDL may generate a higher transcytotic rate. Com- 
parable observations have been recorded in studies on rat and 
human LDL catabolism by the rat liver (48). 
From the experiments reported here, it appears that transcy- 
tosis across the endothelial cell is the primary rate--limiting 
step in LDL transport through the arterial wall. 
The relatively small amount of LDL detectable  as fully or 
partially intact particles within the subendothelium (as com- 
pared to the number of LDL particles visualized on the cell 
surface or within plasmalemmal vesicles)  may be explained in 
several ways. One possibility is that  LDL degradation  starts 
even during its contact with the endothelial cell membrane or 
while being transported within plasmalemmal vesicles.  Such a 
process implies the existence, in those locations, of an extra- 
hepatic lipaselike  activity comparable to that reported in rat 
adrenals (33).  As a  result of this possible extralysosomal hy- 
drolysis, the number of intact LDL particles detectable in the 
subendothelial space would be much smaller than expected; at 
least some of the LDL may occur in this location as apoprotein 
B and cholesterol. It is possible that in vivo such LDL uptake 
by a low-affinity mechanism and receptor-independent degra- 
dation of LDL by the endothelial cell may be a salient process 
especially in hyperlipoproteinemic conditions. 
Since the arterial endothelinm is not provided with a partic- 
ularly  rich  lysosomal apparatus,  a  major  processing  of the 
excess LDL in vivo within this endothelial compartment with 
subsequent cholesterol efflux appears unlikely. 
VASII.E  ET  AL  Lipoprotein in the Arterial Endothefiurn  1687 The lack of LDL accumulation within the subendothelium, 
in areas in which the endothelium was accidentally damaged, 
supports the  idea that  LDL transcytosis  is an active process 
implemented and monitored by the endothelial cell itself.  This 
inquiry  is  now  being  extended  to  the  immunocytochemical 
detection of autologous LDL in vivo (work in progress). 
We  greatly  appreciate  the  excellent  technical  assistance  of  Stefania 
Tancov,  Elena  Florea,  M.  Misici,  M.  Mitroaica,  V.  Ionescu,  D.  Con- 
stantinescu,  and  C. Stancu. 
Part  of  the  work  with  LDL-ferntin  conjugate  was  carried  out  in 
collaboration  with  Dr. Anca  Nistor,  from  the same  institute. 
The  research was supported  by the Ministry of Education,  Romania, 
by  National  Institutes  of Health  grant  HL-26343  from  the  National 
Heart,  Lung  and  Blood  Institute,  U.S.A., and  by funds  made  available 
through  the 1978 International  Arthur  and  Louise Lucian  Award  given 
to Nicolae  Simionescu  and  Maya  Simionescu. 
Part  of the results  reported  in this paper  were  previously  presented 
at  the  Second  International  Congress  on  Cell  Biology,  West  Berlin, 
August  1980,  and  published  in abstract  form  (59). 
Received for publication  29 April 1982,  and in  revised form  2  February 
1983. 
REFERENCES 
1.  Adams, C. W. M. 1981. Lipoprotein  filtration  in atherogenesis.  Evidence  from experimen- 
tal and human pathology.  In Lipoproteins,  Atherosclerosis  and Coronary Heart Disease. 
N. E. Miliar and B. Lewis, editors. Elsevier/North Holland Biomedical  Press, Amsterdam. 
91-106. 
2.  Aladjem,  F. 1966. Immanoelectrophoretic  properties  of low-density  human serum llpo- 
proteins.  Nature (Lend.).  5027:1003-1005. 
3.  Anderson,  R. G. W., J. L. Goldsrein,  and M. S. Brown.  1976. Localization  ofinw density 
lipoprotein  receptors on plasma membrane of normal human fibrobiasts and their absence 
in ceng from a familiar hypereholesterolemia  homozygote.  Prec. Natl. Acad. Sci.  USA. 
73:2434-2438. 
4.  Barak, L. S., and W. W. Webb. 1981. Fluorescent  low density lipoprotein  for observation 
of dynamics of individual  receptor  complexes on cultured  human fibroblasts.  J. Cell Biol. 
90:595-604. 
5.  Bratzler,  R. L., G. M. Chisohn,  C. K. Cotton,  K. A. Smith,  and R. S. Lees.  1977. The 
distribution  of labeled  low-density  lipoproteins  across  the rabbit thoracic  aorta in rive. 
Atherosclero~.  28:289-307. 
6.  Brown, M. S., P. T. Kovanen, and 3. L. Goldstein.  1981. Regulation  of plasma cholesterol 
by llpoprotein  receptors.  Science (Wash. DC). 212:628-635. 
7.  Brown,  W. V., R. I. Levy, and D. S~ Fredrickson.  1969. Studies  of the proteins  in human 
plasma very low density lipoproteins.  J. Biol. Chem. 244:5687-5694. 
8. Calandra,  S.,  I.  Pasqnali-Rouchetti,  E.  Gherardi,  C.  Foruieri,  and  P.  Tarugi.  1977. 
Chemical and morphological  changes of rat plasma llpoproteins  after a prolonsed admin- 
istration  of diets containing olive oil and cholesterol.  Atherosclerosis. 28:369-387. 
9.  Carpentier,  J.-L, P. Gorden, J. L. Goldstein,  R. G. W. Anderson,  M. S. Brown,  and L. 
Orci.  1979. Binding and  internalization  of ~z~I-LDL in  normal  and  mutant  human 
fibroblasts.  Exp. Cell Res. 212:135-142. 
10.  Chao, Y. S., E. E. Windler, G. Chi Chen, and R. L Hovel.  1979. Hepatic catabolism  of rat 
and  human  lipoproteins  in  rats  treated  with  17-ct-ethinyl  estradloL  Z  Biol.  Chem. 
254: l 1360- [ 1366. 
IL Chan,  Y.  S.,  A.  L. Jones,  G. T.  Hradek,  E.  E.  T.  Windler,  and  R.  J.  Hovel.  1981. 
Autographic localization  of the sites of uptake,  cellular  transport,  and catabolism  of low 
density lipoproteins  in the liver of normal and estrogen-treated  rats. Prec. Natl. Acad. Sci. 
USA. 78:597Jo01. 
12.  Chapman, M. J. 1980. Animal lipoproteins:  chemistry,  structure  and comparative aspects. 
J. L4pid Re& 21:789-853. 
13.  Clarke, H. G. M., and T. Freeman. 1967. A quantitative mamuno¢lectruphoresLs method 
(Laurell  el¢ctrophoresis).  Protides Biol. Fluids Prec. Colloq. 14:503-509. 
14.  Coetzee,  G. A.,  O. Stein,  and Y. Stein.  1979. Uptake and degradation of low  density 
lipoprot¢ins  (LDL) by confluent,  contact-inhibited  bovine and human endothelial  cells 
exposed to physiological  concentrations  of LDL. Athernsclerosis. 33:42543 I. 
15.  Drevon,  C.  A.,  A.  D. Attic,  S. H. Pangburn,  and  D. Steinberg.  1981. Metabolism  of 
homologous  and hcterulogons  llpopruteins  by cultured  rat and human skin fibroblasts.  J. 
L~vid Res. 22:37--46. 
16.  Eisenberg,  S., D. Rachmilewit~ R. I. Levi, D. W. Bitheimer,  and F. T~ Lindgren.  [975. 
Pathways of llpoprotein  metabolism:  integration  of structure,  function and metabolism.  In 
Lipid, Lipoproteins,  and Drugs. D. Kritchevsky,  R. Paoletti,  and W. L. Holmes,  editor. 
Plenum Press, New York. 61-76. 
17.  Falcone,  D. I., D. P. Haiiar, and C. R. Minick.  1980. Enhancement of cholesterol  and 
cholesteryl  ester accumulation in re-endothelized  aorta. Am. J. Pathol. 99:81-104. 
18.  Fielding,  P. E., L Vlodavskaj, D. Gospodarowicz,  and C. J. Fi¢ldin s. 1979. Effect of contact 
inhibition  on the regulation  of cholesterol  metabolism in cultured  vascular endothelial 
cells. J. BioL Chem. 254:749-755. 
19.  Finkelstein,  .I.N.,  S.  Ghosh,  and  I.  S.  Schweppa.  1976. Kinetics analysis  of in rive 
llpoprutein  flux in the normal rabbit aorta. Artery. 2:161-172. 
20.  Fried, M., H. G. Wilcox, G. R. Faloona,  S. P. Eoff, M. S. Hoffman, and D. Zimmennan. 
1968. The biosynthesis  of plnsma lipoproteins  in higher animals. Cutup. Biochem. Physiol. 
25:651~61. 
21.  Ghnsh, S, J. M. Finkelstein,  D. B. Moss,  and J. S. Schweppe.  1976. Evaluation  of the 
1688  THE  JOURNAL  OF  CELL BIOLOGY  - VOLUME  96,  1983 
permeability parameters (iJLflUX,  effiux, and volume of distribution)  of arterial  wall  for 
LDL and other proteins.  Adv. Exp. Med. Biol. 67:191-204~ 
22.  Goldstein,  J. L., S. K. Basn, G. Y. Brunschede,  and M. S. Brown.  1976. Release  of low 
density lipoprotein  from its cell surface receptor  by sulfated  giycosaimnoglycans.  Cell. 
7:85-95. 
23.  Goldstein,  J. L., and M. S. Brown.  1977. The low-density  lipoprotein  pathway and its 
relation  to atheruscierosis.  Annw Rev. Biochem. 46:897-930. 
24.  Goldstei~ J. L, R. G. W. Anderson,  and M. S. Brown.  1979. Coated pits, coated  vesicles, 
and receptor-mediated  endooytosis.  Nature (Lend) 5715:679-685. 
25.  Handley,  D. A., C. M. Arbeeny,  L. D. White,  and S. Chian.  1981. Colloidal  gold-LDL- 
conjugates  as membrane probe receptors.  Prec. Natl. Acad. $ci. USA. 78:368-371. 
26.  Have[  R.  J.,  H.  A.  Eder,  and  J.  H.  Bregdon.  1955.  The  distribution  and  chemical 
composition  of ultracentrifugally  separated lipoproteins  in human serum. J.  Clin. Invest. 
34:1345-1353. 
27.  Hanrikscn, T, S. A. Evensen,  and B. Carlander. 1979. Injury to cultured  endothelial  cells 
induced by low density lipoproteins:  protection  by high density lipoproteins.  Scand  J. 
Cli~ Lab. Invest. 39:369-375. 
28.  Henriksen,  T, S. A. Even,sen, J. P. Blomhoff,  H. Torsvik, and B. Cadander.  1979. The 
effect of serum llpoproteins  on cholesterol content and sterol exchange in cultured  human 
endothelial  cells. B~ochim. Biophys. Acta~ 574:312-320. 
29.  Huff, H. F., and J. W.  Ganbatz.  1977. Ultrastructural  localization  of apoprotein  B  in 
human aortic and coronary athesnsclerotic  plaques.  Exp. Mol. Pathol. 26:214-227. 
3@  Huff, H. F., C. L. Herdetmaa, A. M. Gotto, and J. W. Bauhatz.  1977. Apolipoprotein  B 
retention  in the grossly normal and atheroselerotic  human aorta.  Circ. Res. 41:684--692. 
31.  Hollander,  W. 1977. Role of arterial  llpoproteins  in the formation of the fibrous plaque. 
In Atherosclerosis:  Metabolic,  Morphologic  and Clinical  Aspects. G. W. Manni$, and M. 
D. Haust, editors.  Plenum Press, New York. 793-799. 
32.  Ianerarity, T. L, R. E. Pitas, and R. W. Mahley.  1980. Disparities  in the interaction  of rat 
and human lipapruteins  with cultured  rat fibroblnsts  and smooth muscle  cells. J.  Biol. 
Chem. 255:11163-11172. 
33.  Jansen, H., C. Kalkman, J. C. Birkenhager,  and W. C. Huismann. 1980. Demonstration 
of beparin-releasable  liver-like  activity  in rat adrenals.  FEBS Lett. (Fed. Fur. Biochem. 
Soc.) 112:30-34. 
34.  Karts,  M.  1975. Techniques  of llpidology,  isolation,  analysis  and identification  of lipids. 
Cholesterol. 360-361. 
35.  Kishida, Y., B. R. Olsen,  R. A. Berg, and J. Prokop.  1975. Two improved methods for 
preparing ferritin-protein  conjugates  for el~trun microscopy. J. Cell Biol. 64:331-339. 
36.  Kriegur, M., L. C. Smith,  R. G. W. Anderson,  J. L. Gold.stein, Y. L. Kao, H. J. Pownall, 
A. M. Gotto, J'r., and M. S. Brown.  1979. Reconstituted  low density lipoprotein:  a vehicle 
for the delivery  of hydrophobic  fluorescent  probes  to cells. J. Supramol. Struct.  10:467- 
478. 
37.  Kovanen, P.  T,  M.  S.  Brown,  and  J.  L. Goldstein.  1979. Increased  binding of LDL 
(human) to liver membranes from rats treated  with 17-ct-ethinyl estradlol.  J. BioL Chem. 
254:11367-11373. 
38.  Kovanen, P. T., D. W. Bilheimer,  J. L. Goldstein,  J. J. Jaremillo,  and M. S. Brown.  1981. 
Regulatory role  for hepatic low density llpoprutein  receptors  in rive in the dog. Prec. 
Natl. Aead. Sci.  USA. 78:1194-1198. 
39.  Lasser,  N~ L., P. S. Roheim, D. Edelstein,  and H. S. Eder.  1973. Serum lipoproteins  of 
normal and cholesterol-fed  rats. Z Lipid Res. 14:1-8. 
40.  Loess, A. 1974. Uranyl acetate as an excellent fbxative for lipopruteins  after electrophoresis 
on agarose gel. Clin. Chim. Acts. 53:43-49. 
41.  Markwell,  K. A. M., M. S. Haas, L. L. Biaber, and E. N. Tolbert.  1978. A modification  of 
the Lowry procedure  to  simplify  protein  determination  in membrane and  lipoprotein 
samples. Anal. Biochern. 87:206-210. 
42.  MilLs, G.  L.,  and  C.  E.  Taylour.  1971. The distribution  and  compositions  of serum 
llpoproteins  in eighteen animah. Cutup. Biochem. Physiol. 40B:489-501. 
43.  Miulck,  C. R., M. B. Stemerman, and W. Insull.  1977. Effect of regenerated endothelium 
on lipid accumulation in the arterial  wall. Pruc. Natl. Acad. Sci. USA. 74:1724-1727. 
44.  Nakane,  P.  K.,  and N. Kawani.  1974. Peroxidase-labeled  antibody,  a  new method  of 
conjugation.  J. Histochem. Cytochem. 22:1084-1091. 
45.  Noble,  R. P.  1968. Electrophoretic  separation of plasma lipopruteins  in agaruse gel. J. 
Lipid Res. 9:693-700. 
46.  NicolL A.,  R.  Duffield,  and B.  Lewis.  1981. Flux of plasma lipoproteins  into human 
arterial intima.  Comparison between grossly  normal and atheromatous intima.  Athero- 
sclerosis. 39:229-242. 
47.  Palade,  G.  E.,  M.  Simionescu,  and  N.  Simionescu.  1979. Structural  aspects  of the 
permeability  of the microvascular endothelium.  Acta Physiol. Scand. Suppl. 463:11-32. 
48.  Pittman, R. C., A. D. Attic, T. E. Carew, and D. Steinberg.  1982. Tissue sites of catabolism 
of rat and bnman low density llpoproteins.  Biochim. Biophys. Acta. 710:7-14. 
49.  de Purry, G. G., and F. D. Collins.  1972. Composition  and concentration  of lipoproteins 
in the serum of normal rats and rats deficient  in essential  fatty acids. Lipids. 7:225-228. 
50.  Radding, C. M., and D. Steinberg.  1960. Studies on the synthesis and secretion of serum 
lipoproteins  by rat liver slices. J. Clin. Invest. 39:1560-1569. 
51.  Reckless, t. P. D., D. B. Weinstein,  and D. Steinberg.  1978. Lipoprotein  and cholesterol 
metabolism in rabbit arterial endothelial  cells in culture.  Biochim. Biophys. Acts. 529:475- 
487. 
52.  Santlllan,  G. G., ]. R. Sehuh,  S. L. Chart,  and R. J. Bins, 1980. Lipoprotein  uptake in 
perfused  arteries:  inhibition  by 7-ketocholesterol.  Artery. 7:384--394. 
53.  Schonfeld,  G., C. Felski, and M. A. Howald.  1974. Characterization  of plasma llpoproteins 
of the genetically  obese hyperlipoproteinemic  Zucker fatty rat. J. Lipid Res. 15:457~g~1. 
54.  Scott, P. J, and P. J. Hurley.  1970. The distribution  ofradio-indinated serum albumin and 
low density lipoprutein  in tissues and the arterial  wall. Atherosclerosis. 11:77-103. 
55.  Sigurdson,  G., N. Simon-Pierre,  and R. J. Hovel  1978. Catabolism of the apoprotein  of 
low density llpopruteins  by the isolated  parfnsed  rat liver. J. Lipid Res. 19:628-634. 
56.  Simionescn,  N., and M. Simionescu.  1976. Galloylglucoses  of low molecular  weight as 
mordant in electron  microscopy.  L Procedure  and evidence  for the mordanting effect. J. 
Cell Biol. 70:608-621. 
57.  Simionescu, N. 1979. The microvascular  endothellum:  segmental differentiations,  transcy- 
tests, selective distribution  of aulonic sites. Adv. Inflammation RES. 1:64-70. 
58.  Simionescn,  N.  1981. Trunscytosis  and traffic of membranes in the endothelial  cell. In 
International  Cell Biology  1980-1981. H. G. Schweiger,  editor.  Springer-Verlag,  Berlin. 
657-672. 
59.  Sinapius,  D. 1980. Lipid deposition  in the media of human coronary arteries.  A theroscle- 
rosis. 37:87-96. 
60.  Smith,  E.  B., and R. S. Siatter.  1973. Lipids and low-density  llpoproteins  in intima in 
relation  to its morphological  characteristics.  Ciba Found. Syrup. 12:39-62. 
61.  Smith,  E. B., and E. M. Staples.  1980. Distribution  of plasma proteins  across the human 
aortic wall  harrier functions  of endothelium  and internal  elastic lamina. Atherosclerosis. 
37:579-590. 62.  Spurt, A. R. 1969. A low viscosity epoxy resin embedding medium for electron  microscopy. 
J. Ultrastruct. Rar. 26:31-43. 
63.  Stein, Y., and O. Stein.  1973. Lipid synthesis  and degradation and lipoprotem  transport in 
mammalian aorta. Ciba Found- Syrup. 12:165-183. 
64.  Stein, O, Y. Stain, and S. Eisenberg.  1973..A radiographic study of the transport  of ~zsI- 
labeled  serum lipoproteins  in rat aorta.  Cell Tissue Res.  138:223-232. 
65.  Seinberg,  D.  1978. Lipoprotain  metabolism:  new insights from cell  biology.  Adv.  Exp. 
Med.  Biol.  109:3-28. 
66.  Steinberg,  D. 1980. Lipoprotein structure  and metabolism:  inhomogeneity,  variability,  and 
species  specificity.  In  Atherosclemsis  V. A. M.  Gotto,  Jr., L. C. Smith, and B. ALlen, 
editors.  Springer Verlag, Heidelberg.  616-623. 
67.  Steinberg,  D. 1981. MetaboLism of lipoproteins  at the cellular  level in relation  to athero- 
sclerosis.  In Lipoprotdns, Atherosderosis and Coronary Heart Disease. N. E. Miller  and 
B. Lewis, editors.  Elsevier/North Holland Biomedical Press. Amsterdam. 31-48. 
68.  Tanber,  J. P., J. Cheng, and D. Gospodamwicz.  1980. Effect  of high and low density 
hpoproteins on proliferation  of cultured  bovine vascular endothelial  cells. J. Clin. Invest. 
66:696-708. 
69.  Vaslle, E., A. Nistor, S. Nedelcu,  M. Simionescu,  and N. Simionescu.  1980. Dual pathway 
of low density lipoprotein  transport through aortic endothelium,  and vasa vasomm in situ. 
Eur. J. Cell Biol. 22:181. 
70.  Vermcer, B. J.,  L. Havekes, M. C. Wijsman, and J. J. Emeis.  1980. Immunoclectromicro- 
scopical investigations on the edsorptive endocytosis  of low density llpoproteins  by human 
fibroblasts.  Exp.  Cell Res. 129:201-210. 
71.  Vlodavsky,  I., E. P. Fielding,  L C. Fielding,  and D. Gospodarowicz.  1978. Role of contact 
inhibition in the regulation of receptor-mediated  uptake of low density lipoprotein  in 
cultured  vascular endothelial  cells, Prec. Natl. Acad.  Sci. USA.  75:356-360. 
72.  Wall,  R.  T.. J. M. HarLan,  L. A. Harker, and G. E.  Striker.  1980. In vitro effects  of 
hyperlipoproteinemic  sera on human endothelium:  inhibition  of endothelial  c¢11 migration 
by famiLiar hyperehulcsterolemic  sera.  Thromb. Res. 17:753-765. 
73.  Willingham, M. C.,and S. S.Yamada. 1978.A mechanism for the destmctionofpinosomes 
in cultured fibroblasts.  Piranhalysis.  J. Cell Biol. 78:480-488. 
74.  Windier,  E.  E. T.,  P.  T. Kovanen,  Y. S.  Chao,  M.  S.  Brown,  R. J.  Havel, and L  L. 
Guldstein.  1980. The estradiol  stimulated lipoprotein  receptors  of rat liver. A binding site 
that mediates the uptake of rat lipoproteins  containing apoprotein  B and apoprotein  E. J. 
Biol. Chem. 255:10464-10471. 
75.  Winter, A. K. E., and U. B. Anderson.  1977. Analytical  electrofocusing  in thin layers  of 
polyacrylamide  gels. LKB Application  Note. LKB Produktor AB, Broma, Sweden. 250:1- 
13. 
76.  Zllversmith,  D.  B., and  L. B.  Hugues.  1973. Incorporation  in rive of labeled  plasma 
cholesterol  into aortas of young and old rabbits.  Atherosclerosis. 18:141-[52. 
VASILE  [T  AL.  Lipoprotein in the Arterial Endothefium  1689 